NasdaqGM - Nasdaq Real Time Price USD
Prime Medicine, Inc. (PRME)
1.7850
+0.0050
+(0.28%)
As of 12:35:16 PM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ARCH VENTURE PARTNERS X LLC Beneficial Owner of more than 10% of a Class of Security | Purchase | Feb 15, 2024 | -- |
| GOTTESDIENER KEITH MICHAEL Chief Executive Officer | Stock Gift | Oct 8, 2024 | -- |
| GV 2019 GP, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale | Jun 21, 2023 | -- |
| LIU DAVID R Beneficial Owner of more than 10% of a Class of Security | Stock Gift | Jul 21, 2023 | 20,156,900 |
| NELSEN ROBERT TAYLOR Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Feb 15, 2024 | -- |
Related Tickers
BEAM Beam Therapeutics Inc.
19.62
-1.26%
VERV Verve Therapeutics, Inc.
5.71
+4.39%
NTLA Intellia Therapeutics, Inc.
8.11
+0.25%
CRBU Caribou Biosciences, Inc.
0.8391
-0.38%
EDIT Editas Medicine, Inc.
1.5750
+0.96%
ABSI Absci Corporation
3.2000
+0.31%
FATE Fate Therapeutics, Inc.
1.3750
+3.38%
SANA Sana Biotechnology, Inc.
1.7352
+1.47%
MGX Metagenomi, Inc.
1.7200
-2.82%
DYN Dyne Therapeutics, Inc.
11.14
+3.34%